DO + CO AG/ AT0000818802 /
5/9/2024 10:59:21 PM | Chg. +2.800 | Volume | Bid10:59:21 PM | Ask10:59:21 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
145.200EUR | +1.97% | - Turnover: - |
145.200Bid Size: - | 146.800Ask Size: - | 1.42 bill.EUR | 0.69% | 42.33 |
GlobeNewswire
12:45 AM
CLASS ACTION NOTICE FOR CC: Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Sharehol...
Newsfile Corp
12:26 AM
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Impo...
GlobeNewswire
12:16 AM
ROSEN, A LEADING LAW FIRM, Encourages Rivian Automotive, Inc. Investors to Secure Counsel Before Imp...
Newsfile Corp
5/9
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Perion Network Ltd. Investors to Secure Counsel Before I...
Newsfile Corp
5/9
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure ...
GlobeNewswire
5/9
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before ...
Newsfile Corp
5/9
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Lincoln National Corporation Investors to Secure C...
GlobeNewswire
5/9
ECN Capital Reports US $0.00 in Adjusted Net Income per Common Share in Q1-2024 Triad results signif...
GlobeNewswire
5/9
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
5/9
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...